Tumor necrosis factor-α and apoptosis induction in melanoma cells through histone modification by 3-deazaneplanocin A.
Department of Molecular Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California, USA.
Ryo
R
Tanaka
Department of Molecular Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California, USA.
Nicholas C
NC
Donovan
Department of Molecular Pharmacology, Cancer Biology and Pharmacology, Genome Institute of Singapore, Singapore.
Qiang
Q
Yu
Department of Biotechnology Science, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California, USA.
Reiko F
RF
Irie
Department of Molecular Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California, USA. Electronic address: hoon@jwci.org.
Dave S B
DSB
Hoon
D000241:Adenosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D043383:Adenosylhomocysteinase / Q000037:antagonists & inhibitors; D017209:Apoptosis / Q000187:drug effects*; D045744:Cell Line, Tumor; D006657:Histones / Q000378:metabolism; D006801:Humans; D008545:Melanoma / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D012878:Skin Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D006657:Histones; D014409:Tumor Necrosis Factor-alpha; C048460:3-deazaneplanocin; D043383:Adenosylhomocysteinase; D000241:Adenosine